Canada PGx Study Seeks Markers for Drug Reactions in Children | GenomeWeb

NEW YORK (GenomeWeb News) — Canada will start a new pharmacogenomics program to seek predictive genomic markers that could indicate adverse drug reactions in children by harnessing information from an ADR research network that stretches across the country.

The aim of the C$3.9 million ($3.2 million) project is to find out why some drugs cause ADRs in some children and not others, and then to create diagnostic tests to predict and prevent specific reactions, Genome BC said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.